Tribenoside + Lidocaine hydrochloride
This medicine should always be used exactly as described in the patient leaflet or according to the doctor's or pharmacist's instructions.
Procto-Glyvenol in the form of a rectal cream is a medicine intended for the local treatment of external and internal hemorrhoids. Tribenoside has anti-inflammatory, anti-edematous, analgesic, anti-itching effects, and also counteracts damage to the vascular endothelium. Lidocaine is a local anesthetic and relieves symptoms caused by hemorrhoids, such as itching, burning, and pain. Procto-Glyvenol in the form of a rectal cream acts locally, practically without systemic action.
Before starting to use Procto-Glyvenol in the form of a rectal cream in patients with liver function disorders, it should be discussed with a doctor. Procto-Glyvenol in the form of a rectal cream should be used with caution in patients with severe liver damage. In addition to the treatment of hemorrhoids with Procto-Glyvenol, it is recommended to maintain proper hygiene of the anal area, use appropriate physical exercises, and follow a suitable diet to maintain a soft stool consistency. The medicine should not be taken orally. Contact with the eyes should be avoided.
This medicine should not be used in children, as there are no data available on the safety of use in this age group.
No interactions with other medicines have been reported so far. The doctor or pharmacist should be informed about all medicines currently or recently used by the patient, as well as about medicines that the patient plans to use, including those available without a prescription.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult a doctor or pharmacist before using this medicine. Procto-Glyvenol in the form of a rectal cream should not be used during the first 3 months of pregnancy. Procto-Glyvenol in the form of a rectal cream may be used from the 4th month of pregnancy and during breastfeeding, provided that the recommended doses are not exceeded.
Procto-Glyvenol in the form of a rectal cream has no influence or negligible influence on the ability to drive and use machines.
Cetyl alcohol may cause local skin reactions (e.g., contact dermatitis). Methyl parahydroxybenzoate and propyl parahydroxybenzoate may cause allergic reactions (possible late reactions). The packaging of the medicine contains latex. It may cause severe allergic reactions.
This medicine should always be used exactly as described in the patient leaflet or according to the doctor's or pharmacist's instructions. In case of doubts, the doctor or pharmacist should be consulted. Procto-Glyvenol in the form of a rectal cream should be used in the morning and evening until the acute symptoms disappear. Then the dose can be reduced to using the cream once a day. In the case of treating internal hemorrhoids, the cream should be applied using the attached applicator, which should be screwed onto the thread of the tube. The applicator is equipped with a protective cap. It should be removed before using the cream and put back in place after application. The recommended doses of the medicine should not be exceeded. Contact with the eyes should be avoided. Hands should be washed thoroughly after each use of the medicine. The medicine should not be taken orally.
This medicine should not be used in children, as there are no data available on the safety of use in this age group.
Procto-Glyvenol in the form of a rectal cream should be used until the symptoms disappear. If after 7 days of use there is no improvement or other, previously unobserved symptoms appear, the doctor should be consulted to rule out other potential causes of these complaints.
No cases of overdose with Procto-Glyvenol in the form of a rectal cream have been reported. There is no specific antidote for lidocaine. Overdose should not occur when using the medicine according to the recommended dosage regimen. In case of overdose, the doctor should be consulted immediately.
A double dose should not be used to make up for a missed dose.
In case of further doubts related to the use of this medicine, the doctor or pharmacist should be consulted.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following terms are used to describe the frequency of side effects: rare side effects(more than 1 person in 10,000, less than 1 person in 1,000):
Very rare side effects(may occur in up to 1 person in 10,000):
If any side effects occur, including any side effects not listed in the leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products
Very common | occurs in more than 1 person in 10 |
Common | occurs in 1 to 10 people in 100 |
Uncommon | occurs in 1 to 10 people in 1,000 |
Rare | occurs in 1 to 10 people in 10,000 |
Very rare | occurs in less than 1 person in 10,000 |
Unknown | frequency cannot be estimated from the available data |
of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products Al. Jerozolimskie 181C 02-222 Warsaw Tel.: + 48 22 49 21 301 Fax: + 48 22 49 21 309 website: https://smz.ezdrowie.gov.pl By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children. Store in a temperature below 25°C, in the original packaging. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month. Medicines should not be disposed of via wastewater or household waste containers. The pharmacist should be asked how to dispose of medicines that are no longer used. This will help protect the environment.
Procto-Glyvenol in the form of a rectal cream is a white, homogeneous cream. Available packaging: aluminum tube with a PE cap, which contains 30 g of rectal cream. Applicator made of LDPE. For more detailed information, the marketing authorization holder or parallel importer should be contacted.
Haleon Hungary Kft. Csörsz utca 43 1124 Budapest Hungary
Haleon Germany GmbH Barthstraße 4 80339 Munich Germany
Delfarma Sp. z o.o. ul. Św. Teresy od Dzieciątka Jezus 111 91-222 Łódź
Delfarma Sp. z o.o. ul. Św. Teresy od Dzieciątka Jezus 111 91-222 Łódź Nr of the permit in Bulgaria, the country of export: 20000821
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.